Vincent Ngai

Long-Term Lamivudine Therapy Reduces the Risk of Long-Term Complications of Chronic Hepatitis B Infection even in Patients without Advanced Disease

Man‐Fung Yuen, Wai‐Kay Seto, Danny Hoi-Fan Chow et al. · Antiviral Therapy · 2007 · 254 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Reduction of covalently closed circular DNA with long-term nucleos(t)ide analogue treatment in chronic hepatitis B

Ching‐Lung Lai, Danny Wong, Philip P.C. Ip et al. · Journal of Hepatology · 2016 · 177 citations · Full text

Pharmacy, Biotechnology, Molecular Biology +13

One-Year Entecavir or Lamivudine Therapy Results in Reduction of Hepatitis B Virus Intrahepatic Covalently Closed Circular DNA Levels

Danny Ka‐Ho Wong, Man‐Fung Yuen, Vincent Ngai et al. · Antiviral Therapy · 2006 · 103 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

A Randomized Placebo-Controlled, Dose-Finding Study of Oral Lb80380 in Hbeag-Positive Patients with Chronic Hepatitis B

Man‐Fung Yuen, John Kim, Chung Ryeol Kim et al. · Antiviral Therapy · 2006 · 46 citations · Full text

Pharmacy, Clinical Pharmacokinetics, Pharmacokinetics +17

Pharmacokinetics of LB80331 and LB80317 following Oral Administration of LB80380, a New Antiviral Agent for Chronic Hepatitis B (CHB), in Healthy Adult Subjects, CHB Patients, and Mice

Man‐Fung Yuen, Sung‐Hack Lee, Hyang-Mi Kang et al. · Antimicrobial Agents and Chemotherapy · 2009 · 23 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +14